194 related articles for article (PubMed ID: 17653086)
1. Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer.
Jones LP; Tilli MT; Assefnia S; Torre K; Halama ED; Parrish A; Rosen EM; Furth PA
Oncogene; 2008 Jan; 27(6):794-802. PubMed ID: 17653086
[TBL] [Abstract][Full Text] [Related]
2. Responsiveness of
Alothman SJ; Wang W; Goerlitz DS; Islam M; Zhong X; Kishore A; Azhar RI; Kallakury BV; Furth PA
Cancer Prev Res (Phila); 2017 Apr; 10(4):244-254. PubMed ID: 28283467
[TBL] [Abstract][Full Text] [Related]
3. Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer.
Jones LP; Li M; Halama ED; Ma Y; Lubet R; Grubbs CJ; Deng CX; Rosen EM; Furth PA
Oncogene; 2005 May; 24(22):3554-62. PubMed ID: 15750629
[TBL] [Abstract][Full Text] [Related]
4. Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.
Miermont AM; Parrish AR; Furth PA
Carcinogenesis; 2010 Jun; 31(6):1124-31. PubMed ID: 20181624
[TBL] [Abstract][Full Text] [Related]
5. The PPARγ agonist efatutazone increases the spectrum of well-differentiated mammary cancer subtypes initiated by loss of full-length BRCA1 in association with TP53 haploinsufficiency.
Nakles RE; Kallakury BV; Furth PA
Am J Pathol; 2013 Jun; 182(6):1976-85. PubMed ID: 23664366
[TBL] [Abstract][Full Text] [Related]
6. Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.
Herynk MH; Lewis MT; Hopp TA; Medina D; Corona-Rodriguez A; Cui Y; Beyer AR; Fuqua SA
Oncogene; 2009 Sep; 28(36):3177-87. PubMed ID: 19561644
[TBL] [Abstract][Full Text] [Related]
7. Retroviral transduction of splice variant Brca1-Delta11 or mutant Brca1-W1777Stop causes mouse epithelial mammary atypical duct hyperplasia.
Bachelier R; Vincent A; Mathevet P; Magdinier F; Lenoir GM; Frappart L
Virchows Arch; 2002 Mar; 440(3):261-6. PubMed ID: 11889595
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice.
Feng Y; Manka D; Wagner KU; Khan SA
Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14718-23. PubMed ID: 17785410
[TBL] [Abstract][Full Text] [Related]
9. Comparison of increased aromatase versus ERα in the generation of mammary hyperplasia and cancer.
Díaz-Cruz ES; Sugimoto Y; Gallicano GI; Brueggemeier RW; Furth PA
Cancer Res; 2011 Aug; 71(16):5477-87. PubMed ID: 21840986
[TBL] [Abstract][Full Text] [Related]
10. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
11. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
[TBL] [Abstract][Full Text] [Related]
12. BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling.
van de Ven M; Liu X; van der Burg E; Klarenbeek S; Alexi X; Zwart W; Dijcks F; Bouwman P; Jonkers J
J Pathol; 2018 Sep; 246(1):41-53. PubMed ID: 29877575
[TBL] [Abstract][Full Text] [Related]
13. Prolactin potentiates transforming growth factor alpha induction of mammary neoplasia in transgenic mice.
Arendt LM; Rose-Hellekant TA; Sandgren EP; Schuler LA
Am J Pathol; 2006 Apr; 168(4):1365-74. PubMed ID: 16565509
[TBL] [Abstract][Full Text] [Related]
14. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
[TBL] [Abstract][Full Text] [Related]
15. Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes.
Arendt LM; Evans LC; Rugowski DE; Garcia-Barchino MJ; Rui H; Schuler LA
J Endocrinol; 2009 Oct; 203(1):99-110. PubMed ID: 19635758
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY
Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107
[TBL] [Abstract][Full Text] [Related]
17. A role of estrogen/ERalpha signaling in BRCA1-associated tissue-specific tumor formation.
Li W; Xiao C; Vonderhaar BK; Deng CX
Oncogene; 2007 Nov; 26(51):7204-12. PubMed ID: 17496925
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Estrogen Signaling Reduces the Incidence of
Baek HJ; Kim SE; Choi EK; Kim JK; Shin DH; Park EJ; Kim TH; Kim JY; Kim KG; Deng CX; Kim SS
Int J Biol Sci; 2018; 14(12):1755-1768. PubMed ID: 30416390
[TBL] [Abstract][Full Text] [Related]
19. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.
Nakles RE; Shiffert MT; Díaz-Cruz ES; Cabrera MC; Alotaiby M; Miermont AM; Riegel AT; Furth PA
Mol Endocrinol; 2011 Apr; 25(4):549-63. PubMed ID: 21292825
[TBL] [Abstract][Full Text] [Related]
20. Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology.
Shyamala G; Chou YC; Cardiff RD; Vargis E
Cancer Res; 2006 Nov; 66(21):10391-8. PubMed ID: 17079459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
